Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

BlueHealer secures $135,000 in non-dilutive funding to develop limb-saving surgical device for lower-limb amputation prevention.

PRIVATEOct 09, 2026

Amount Raised

$135,000

Round Type

Pre-Seed

BaltimoreBiotechnologyHealth CareMedicalMedical Device

Investors

Pava Center for EntrepreneurshipHarbor Designs and ManufacturingTedco

Description

BlueHealer, a Baltimore-based biotech startup founded in 2024, has secured $135,000 in non-dilutive funding to advance its device supporting Tibial Transverse Transport (TTT), a surgical technique that improves blood flow to prevent lower-limb amputations. The funding was provided through key ecosystem partners including TEDCO, Harbor Designs and Manufacturing, and the Pava Center for Entrepreneurship. The device addresses a critical healthcare need, as approximately 150,000 Americans undergo lower-limb amputations annually due to chronic conditions like diabetes and arterial disease. BlueHealer's cofounders, who developed the concept while studying biomedical engineering at Johns Hopkins University, aim to make this limb-saving technology more accessible, particularly to underserved communities disproportionately affected by amputation.

Company Information

Company

BlueHealer

Location

Baltimore, Maryland, United States

About

BlueHealer is a Baltimore-based biotech startup developing an internal device to perform Tibial Transverse Transport (TTT), a surgical procedure designed to improve blood flow and prevent lower-limb amputations. The company was founded by Jay Tailor, Santiago Rentería, and Mitchell Lipke, who were inspired by their experiences in operating rooms at Johns Hopkins University. BlueHealer's internal device approach aims to provide a safer alternative to existing external frame systems by reducing infection risks and fracture complications. The startup is addressing a critical healthcare disparity, as lower-income and Black communities experience disproportionately higher amputation rates due to diabetes and arterial disease.

Fundz sees it the moment BlueHealer raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for BlueHealer's next move

See what Strategic adds

BlueHealer raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.